ArticleScientific reports2025
Prebiotic properties and antioxidant effect of crude extracts and polysaccharides from Agaricus bisporus and Pleurotus ostreatus mushrooms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Antioxidant and antibacterial potency of Pleurotus citrinopileatus: by GC-MS characterization, bioactive compound profiling, synergy analysis, and In-Silico validation of microbial target interactions.Folia microbiologica · 2026Article
- The mycobiome, virome and archaeome in gastrointestinal cancers: molecular pathogenesis and therapeutic intervention.Molecular cancer · 2026Review
- Selective Carbohydrate Modulation Enhances BLIS-Mediated Bioprotection Against Multidrug-Resistant Foodborne Pathogens During Vegetable Fermentation.Current microbiology · 2026Article
- Advances in antioxidant activities of edible mushroom polysaccharides: status, influencing factors, mechanisms, and applications.Frontiers in nutrition · 2026Review
- Modulating the Gut Microbiome in Type 2 Diabetes: Nutritional and Therapeutic Strategies.Nutrients · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modifying the gut microbiome, also known as bacteriotherapy, is a key strategy that uses probiotics, prebiotics, or synbiotics to reduce inflammation and fight infection and colonization by pathogenic bacteria. Various food sources, particularly those rich in Lactobacillus species, are well-recognized for their probiotic properties. Edible mushrooms are rich with their nutrient-dense composition, including carbohydrates, proteins, fibers, minerals, vitamins, and lipids, which stand out as a promising bio-source for several biological uses. In this study, four probiotic strains were isolated and identified from food samples: Lactobacillus acidophilus (L. acidophilus), L. pentosus, L. plantarum, and L. paracasei. Then the prebiotic and antioxidant properties of crude and polysaccharide extracts were assessed from two edible mushrooms, Agaricus bisporus (brown) and Pleurotus ostreatus (oyster). Using the phenol-sulfuric acid method, the ethanol extract of P. ostreatus exhibited the highest yields of total carbohydrates and reducing sugars (6.14 and 3.15 mg/mL, respectively). Among the mushroom extracts, the polysaccharide from A. bisporus demonstrated the strongest radical scavenging activity (93.73%), with a half-maximal effective concentration (EC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.